F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 44 filers reported holding F-STAR THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $398 | -99.9% | 63,047 | 0.0% | 0.00% | – |
| Q3 2022 | $323,000 | -91.5% | 63,047 | -89.7% | 0.00% | – |
| Q2 2022 | $3,816,000 | +36.1% | 609,654 | -22.8% | 0.00% | – |
| Q1 2022 | $2,803,000 | -34.9% | 789,590 | -8.0% | 0.00% | – |
| Q4 2021 | $4,308,000 | -28.5% | 858,095 | +4.2% | 0.00% | -100.0% |
| Q3 2021 | $6,027,000 | -15.2% | 823,382 | -0.5% | 0.00% | 0.0% |
| Q2 2021 | $7,110,000 | – | 827,728 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 574,996 | $2,944,000 | 1.06% |
| AlphaCentric Advisors LLC | 165,000 | $845,000 | 0.87% |
| DAFNA Capital Management LLC | 576,881 | $2,954,000 | 0.80% |
| Knott David M Jr | 235,945 | $1,208,000 | 0.51% |
| Atlas Venture Life Science Advisors, LLC | 599,524 | $3,070,000 | 0.34% |
| S. MUOIO & CO. LLC | 40,000 | $205,000 | 0.27% |
| Murchinson Ltd. | 162,624 | $833,000 | 0.24% |
| Connolly Sarah T. | 53,001 | $271,000 | 0.20% |
| BCK CAPITAL MANAGEMENT LP | 52,000 | $266,000 | 0.19% |
| Diametric Capital, LP | 44,449 | $228,000 | 0.12% |